This study demonstrates the power of real-time glucose information for people with Type 2 diabetes treated with basal insulin
Abbott’s latest innovation promises to shift diabetes management from reactive to proactive
AFib is a progressive condition where timely intervention is critical to disease management and, ultimately, the patient's quality of life
The system is intended for some of the tiniest patients—premature infants weighing as little as two pounds
Globally, Abbott has received reports of 736 severe adverse events linked to the issue, including seven deaths (none in the US)
Abbott is eyeing to become a global powerhouse in early cancer detection and precision oncology
The new formulation features what Abbott calls a “triple care system,” anchored by a blend of nutrients aimed at supporting blood sugar control and metabolic health
The company has posted net profit of Rs. 1,414.44 crores for the Financial Year ended March 31, 2025
Mistry is a seasoned finance professional having an extensive work experience spanning more than 25 years
Anushree has been with Abbott since 2021 and currently serving as Head of Strategy and Portfolio
Subscribe To Our Newsletter & Stay Updated
